Evidence map›Paper›PMID 41989306›Full record

ArticleJournal of virology2026

A major histocompatibility complex (MHC) class II molecule that binds the same viral pathogen peptide with both nonamer and decamer core sequences for presentation to T cells.

Anastasia Goryanin, Atlanta G Cook, Shahriar Behboudi, Jim Kaufman, Samer Halabi

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anastasia GoryaninAshworth Laboratories, Institute for Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-1931-1947
Atlanta G CookInstitute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-2087-9772
Shahriar BehboudiVeterinary School, University of Bristol, Langford, United Kingdom.ORCID 0000-0001-6455-4086
Jim KaufmanAshworth Laboratories, Institute for Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-7216-8422
Samer HalabiAshworth Laboratories, Institute for Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-4612-5234

Funding

Biotechnology and Biological Sciences Research Council BB/T020954/2Biotechnology and Biological Sciences Research Council BB/V000756/1German Science Foundation FOR5130 KA 5564/1-1Wellcome Trust Senior Research Fellowship 200898Wellcome Trust WeInvestigator Award 110106/A/15/Z
6 · The paper itself

Abstract

Classical molecules encoded by the major histocompatibility complex (MHC) are central to immune responses. Compared to typical mammals, the chicken MHC is small and simple, determining life or death from economically important pathogens like avian influenza virus and Marek's disease virus (MDV). Several genes within the tightly linked chicken MHC have been suggested to determine resistance and susceptibility to MDV, but it was a surprise to find that the dominantly expressed class II molecule from the resistant B2 haplotype employed a novel peptide-binding mode with a decamer core sequence compared to the susceptible B19 haplotype with a typical nonamer core. We examined the crystal structure of the dominantly expressed class II molecule from another resistant haplotype, B21, which is extremely frequent in commercial chicken flocks, to find that it bound the same MDV peptide with both nonamer and decamer cores, revealing an unexpected plasticity of binding that potentially increases the immune response to this devastating pathogen.IMPORTANCEThe meat and eggs of chickens are major food sources for both developed countries (where vast numbers are produced by the commercial poultry industry) and developing countries (where backyard and village chickens provide animal protein for the poorest members of society). Chickens are beset by many devastating viral diseases, and decades of genetics research has shown the particular haplotype of the major histocompatibility complex (MHC) can determine life or death for an individual chicken. One major economically important virus is the oncogenic herpesvirus that causes Marek's disease virus (MDV). Through structural studies, we find that the dominantly expressed class II molecule from an MHC haplotype that confers decisive resistance to MDV (and a number of other viruses) binds the same MDV peptide in two conformations, thus providing the basis for a wider immune response by T cells, which is of potential importance for both disease resistance and vaccine response.

Indexed as

Antigen PresentationHerpesvirus 2, GallidHistocompatibility Antigens Class IIPeptidesT-LymphocytesAmino Acid SequenceAnimalsChickensCrystallography, X-RayMarek DiseaseModels, MolecularProtein BindingHistocompatibility Antigens Class IIPeptidesadaptive immunityantigen presentationavianvaccine

Identifiers

PMID41989306
PMCPMC13185547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.